| Name | Title | Contact Details |
|---|
Oasis For Orphans (o4o.org) is a non-profit organization dedicated to giving children in Kenya hope for a bright future. We believe that education is the key to unlocking opportunities, but when physical and educational needs are not met, the future be...
At Carolina Pines Regional Medical Center, we "care for our own, right here at home." A leader in providing quality health care services to the people of several counties in northeastern South Carolina, patients have come to rely on our experienced, skilled staff and physicians to provide them with the highest level of care and compassion. Through the facilities on our campus, including a 116-bed acute care hospital and an adjoining medical office building, we provide comprehensive services with two things in mind: the care and comfort of our patients. From routine checkups to complex, state of the art surgery, Carolina Pines Regional Medical Center wants to be your health care provider of choice. Our goal is to be valued for our leadership, expertise and the ability to positively impact the quality of life for the citizens in our service area which includes Darlington, Chesterfield, Lee and Marlboro Counties. It is our privilege to care for our own, right here at home. This hospital is partially owned by physicians.
Northwestern Memorial Hospital (NMH) is one of the country's premier academic medical centers and is the primary teaching hospital of Northwestern University's Feinberg School of Medicine.
isogenix is a Chandler, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.